Professor Catherine Smith
Professor of Dermatology & Therapeutics
Contact details
Biography
Catherine is adjunct Professor of Dermatology and Therapeutics at St John’s Institute of Dermatology, Kings College London, an NIHR Senior Investigator, and Consultant Dermatologist leading national specialised services for adults with severe psoriasis and eczema at Guys and St Thomas NHS Foundation Trust.
Her research aims to deliver disease remission for people with inflammatory skin disease using data-driven, proactive, inclusive precision medicine strategies, and involves national and international collaboration. She’s also interested in guideline development and implementation in the UK and Europe so that research findings influence practice.
Research
Skin Therapy Research Unit
The Skin Therapy Research Unit (STRU) is a dermatology research and clinical trials facility based at St John’s Institute of Dermatology within Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London.
Clinical Diagnostics Development Unit (CDDU)
The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.
News
Meet the Spinouts on King's Spinout Accelerator
10 spinouts derived from King’s research community will explore the commercial potential of their research on the King’s Spinout Accelerator.
Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions
People with inflammatory immune conditions that affect their skin, bowel, and joints have been linked to a greater risk of being hospitalised and death from...
Professor Catherine Smith appointed NIHR Senior Investigator
The role is reserved for outstanding leaders of patient and people-based research.
Outcomes of psoriasis treatment can be predicted by white blood cell response to test, scientists discover
The way type 2 conventional dendritic cells (cDC2) respond to an in vitro test before the patient commences therapy can predict whether the therapy is going...
COVID-19 vaccine: Antibody response weakened in patients receiving methotrexate
The antibody – but not the T cell – response to the first dose of the Pfizer COVID-19 vaccine is weakened in patients taking the immunosuppressant...
Research
Skin Therapy Research Unit
The Skin Therapy Research Unit (STRU) is a dermatology research and clinical trials facility based at St John’s Institute of Dermatology within Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London.
Clinical Diagnostics Development Unit (CDDU)
The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.
News
Meet the Spinouts on King's Spinout Accelerator
10 spinouts derived from King’s research community will explore the commercial potential of their research on the King’s Spinout Accelerator.
Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions
People with inflammatory immune conditions that affect their skin, bowel, and joints have been linked to a greater risk of being hospitalised and death from...
Professor Catherine Smith appointed NIHR Senior Investigator
The role is reserved for outstanding leaders of patient and people-based research.
Outcomes of psoriasis treatment can be predicted by white blood cell response to test, scientists discover
The way type 2 conventional dendritic cells (cDC2) respond to an in vitro test before the patient commences therapy can predict whether the therapy is going...
COVID-19 vaccine: Antibody response weakened in patients receiving methotrexate
The antibody – but not the T cell – response to the first dose of the Pfizer COVID-19 vaccine is weakened in patients taking the immunosuppressant...